Cheryl Cohen
CIK 1529371 · Chief Commercial Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.53M
Companies
9
Total Filings
49
Lifetime Open-Market Net
-$7.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | Director | 215,418 | $7.10 | $1.53M | -$710.4K | 8 | 2026-06-10 |
| CLDX | Director | — | $31.27 | — | $0 | 4 | 2025-06-09 |
| Lite Strategy, Inc. (MEIP) Delisted | Director | — | $3.20 | — | $0 | 4 | 2022-07-07 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Director | 16,160 | $33.00 | $533.3K | $0 | 6 | 2021-07-02 |
| ImmunityBio, Inc. (NK) Delisted | Director | 270,925 | — | — | -$298.8K | 3 | 2020-08-13 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Director | — | — | — | $0 | 3 | 2019-07-15 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Director | — | — | — | $0 | 2 | 2016-06-16 |
| LadRx Corp (CYTXW) Delisted | Director | — | — | — | $0 | 1 | 2015-12-17 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Commercial Officer | 32,436 | — | — | -$6.05M | 11 | 2014-02-20 |
Recent Filings · Page 4 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-05 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-25 | — | Grant (A) | — | $0 | |
| 2016-06-16 | Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-26 | — | Grant (A) | — | $0 | |
| 2015-12-17 | LadRx Corp (CYTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-27 | — | Buy (P) | +3,500 | $25.1K | |
| 2015-07-15 | — | Grant (A) | — | $0 | |
| 2015-04-13 | Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-20 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-06 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +7,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.